-
Backtracking of Leukemic Clones to Birth
Many of the acquired genetic changes that contribute to the molecular pathogenes
-
Integrating Molecular Biomarkers into Current Clinical Management in Melanoma
Personalized melanoma medicine has progressed from histopathologic features to s
-
Proteomics and Cancer Epidemiology
Profiling of differentially expressed proteins is perhaps the most important and
-
Ovarian Cancer Stem Cells Enrichment
The concept of cancer stem cells (CSCs) provides a new paradigm for understandin
-
Epidemiological Investigation of Prostate Cancer
Prostate cancer is the most common male cancer diagnosed in Western populations.
-
Immunohistochemical Evaluation of Biomarkers in Prostatic and Colorectal Neoplasia: Principles and G
In Chapter 10 of thts volume and in prior publications (1 ,2 ), the matertals an
-
Procedures for the Quantitative Protein Determination of Urokinase and Its Inhibitor, PAI-1, in Huma
The determination of the protein content of urokinase-type plasminogen activator
-
Detection of the Transcripts and Proteins for the Transforming Growth Factor- Isoforms and Receptors
Several critical polypeptide growth factors have been identified for the lung, i
-
Use of Proteomics to Study Chemosensitivity
Chemoresistance remains an unresolved problem in clinical oncology. Therefore it
-
Analyzing Cell Cycle Checkpoints After Ionizing Radiation
Several methods to measure cell cycle perturbation after exposure to ionizing ra
-
Manipulating Genes and Gene Copy Number by Bacterial Artificial Chromosome Transfection
Bacterial artificial chromosomes (BACs) provide a well-characterized resource fo
-
DNA Methylation and Histone Modifications in Breast Cancer
Breast cancer is caused by progressive genetic alterations and epigenetic change
-
Diagnosis and Monitoring of CBFB-MYH11-Positive Acute Myeloid Leukemia by Qualitative and Quantitati
During the last decade, many mutations present in myeloid leukemias have been mo
-
Generation and Characterization of p53 Mutant Mice
p53 is one of the most well-characterized members of the tumor suppressor gene f
-
G1 and S-Phase Checkpoints, Chromosome Instability, and Cancer
Mitogen-dependent progression through the first gap phase (G1) of the mammalian
